Heb Extra Stregth Antacid Tablet, Chewable
FDA Recall NDC 37808-136
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Heb Extra Stregth Antacid (NDC 37808-136). A significant event, classified as Class II, was initiated on May 28, 2026 by H E B. The reported reason for this action was: "Presence of foreign substance: small metallic particles in chewable tablets."
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
Class II Ongoing
Presence of foreign substance: small metallic particles in chewable tablets.
May 28, 2026
Jun 10, 2026
N/A
Recall Profile & Regulatory Data
Event ID
99098
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Guardian Drug Co. Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
U.S.A. Nationwide
Product Description
H.E.B Extra Strength Calcium Carbonate Antacid Tablets, Calcium Carbonate 750 mg, 96 Chewable Tablets, MADE WITH PRIDE & CARE FOR H.E.B, 646 S. FLORES ST, SAN ANTONIO, TX, NDC 37808-136-22.
Batch or Lot Expiration Information
Lot# : 1276118, expires: JAN 2029.
Affected Packages Involved in this Recall
37808-136-22Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
